@mylliabio.bsky.social
Primary cell CRISPR screens to accelerate drug discovery and target selection at single-cell resolution
📢 @mylliabio.bsky.social is heading to #IUIS2025 - we’re excited to share that Anke Loregger, Myllia’s Director of R&D, will attend the International Congress of Immunology (IUIS) 2025 in Vienna! Interested in the VISTA platform?
Poster: II.265 on Wednesday, August 20 at 12.15 PM
www.myllia.com
🗓️ @mylliabio.bsky.social sponsors the first conference on "High-Content CRISPR Screening" from March 18-19, 2026 in Vienna: perturb2026.bio
Scientific topics:
🔬 CRISPR-based screening strategies
🧬 Perturb-Seq & CROP-Seq
💻 Computational analyses
💻 AI models of human cells
📸 Image-based screens
🧬 Unlocking target discovery in primary human dendritic cells with VISTA™
At @mylliabio.bsky.social, we’re enabling functional genomics in primary immune cells. Our VISTA™ platform combines pooled CRISPRi with scRNA-Seq to systematically map gene function at scale!
Contact us via: info@myllia.com
🔬 Wrapping up an exciting week at #FOCIS2025 in Boston!
We were thrilled to have Sumit Pawar, Associate Director of R&D at @mylliabio.bsky.social, present our latest research on the VISTA™ platform!
📩 Interested in partnering with Myllia? Reach out to us at info@myllia.com
🧬 Join @mylliabio.bsky.social at #FOCIS2025 in Boston!
We’re excited to share that our colleague Sumit Pawar will be presenting our latest work on the VISTA™ platform at #FOCIS25
📍 Poster: Th146
📅 Date: Thursday, June 26, 2025
myllia.com
Vienna, June 2025 - @mylliabio.bsky.social, a leader in functional genomics in primary human cells, has launched VISTA™ - the first platform enabling CRISPR screens in primary human macrophages and dendritic cells!
www.myllia.com
Press Release: www.biospace.com/press-releas...
Compressed CROP-Seq screens enable functional genomics at scale: At @mylliabio.bsky.social, we are pushing the limits of #CRISPR screening with compressed genome-wide screens — a powerful method for dissecting cellular states and boosting screening capacity without compromising resolution!
20.05.2025 15:00 — 👍 3 🔁 1 💬 0 📌 0
It's about one month to go until BIO US 2025 in Boston!
Are you attending as well? If so, please reach out to our CSO Tilmann Buerckstuemmer and our BD Manager Henrik Schmidt who will be attending #BIO2025 from June 16-19, 2025.
Contact us via:
📩 info@myllia.com
📰 www.myllia.com
Looking forward to representing @mylliabio.bsky.social at the #SwissBiotechDay 2025 in Basel and discussing drug target ID/validation powered by single-cell CRISPR screens in primary human cells!
🎯 Explore Myllia's platform: myllia.com
📩 Contact: info@myllia.com
#TeamMyllia #CRISPR #scRNASeq
We will be at #AACR25 in Chicago, USA
Poster presentation: "A compressed genome-wide CROP-Seq screen to dissect the polarization of THP-1-derived macrophages"
🎯 When: Sunday, April 27 from 2.00 - 5.00 PM EST
🎯 Poster: LB043, Section 52
myllia.com
#CRISPR #scRNASeq #TargetDiscovery #FGX
🚀 At @mylliabio.bsky.social, we're advancing scRNA-Seq in primary human cells with our targeted sequencing (TA-Seq) platform!
Key insights:
• TA-Seq uses 10K reads/cell vs. 50K reads/cell for WTA
• Low-abundance mRNAs are detected more effectively w/ TA-Seq & multiplexed primer panels
myllia.com
A team at @mylliabio.bsky.social contributed one of the largest single-cell #CRISPR #perturbation #screens published today: nature.com/articles/s41...
The lab of Wei Li developed the perturbation-response score (PS) allowing the quantification of diverse perturbation responses in single cells!
🧬 At @mylliabio.bsky.social, we're pushing the boundaries of #scCRISPR screens in primary human T cells. For example, we focus on scalable #CROPSeq screens to uncover key mediators of T helper cell differentiation, particularly Th2 cells!
Reach out via: myllia.com/contact/
#CRISPR #scRNASeq #TCells
📢 One month to go! @mylliabio.bsky.social will be at #BIOEuropeSpring 2025 in Milan, Italy! Would you like to get in touch? Meet our BD Manager @henrik-hs.bsky.social on site to explore #CRISPR-based #functional #genomics screens in primary human cells!
Learn more about CROP-Seq here: myllia.com
Can #AI predict #CRISPR perturbation outcomes?
@mylliabio.bsky.social's CROP-Seq dataset provides a critical resource for AI-driven #Foundation #Models of the Human Cell: myllia.com/resources/cr...
We're the global leader in CRISPR-based functional genomics screens - contact us via info@myllia.com
🔬 At @mylliabio.bsky.social, we're revolutionizing target discovery with CROP-Seq in primary human T cells:
- Custom assay development
- SLICE protocol for functional screening
- Integration of CITE-Seq & scRNA-Seq
Ready to elevate your research? Contact us at info@myllia.com and visit: myllia.com
